secwatch / observer

8-K filed January 13, 2025, 6:59 PM ET ticker JAZZ CIK 0001232524

other confidence low sentiment neutral materiality 0.40

Jazz Pharma confirms FY2024 revenue guidance met at J.P. Morgan conference

Jazz Pharmaceuticals plc

Company expects to meet previously announced total, neuroscience and oncology revenue guidance for year ended Dec 31, 2024.
Outlook disclosed at J.P. Morgan Healthcare Conference on Jan 14, 2025.
No specific revenue or EPS figures provided; guidance ranges unchanged.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-004989
form_type: 8-K
ticker: JAZZ
cik: 0001232524
company_name: Jazz Pharmaceuticals plc
filed_at: 2025-01-13T23:59:59+00:00
discovered_at: 2026-05-14T18:03:03.135542+00:00
generated_at: 2026-05-28T02:52:05.286421+00:00
sec_items: ["2.02", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: low
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-004989
json_url: https://secwatch.observer/filing/0001193125-25-004989.json
markdown_url: https://secwatch.observer/filing/0001193125-25-004989.md
text_url: https://secwatch.observer/filing/0001193125-25-004989.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312525004989/0001193125-25-004989-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312525004989/d699726d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

SCYX

SCYNEXIS effects 1:8 reverse stock split; authorized shares cut to 18.75M

SCYNEXIS INC May 29, 2026, 4:01 PM ET other Items 5.03, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

RLMD

Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment

RELMADA THERAPEUTICS, INC. May 28, 2026, 4:59 PM ET other Items 5.03, 5.07, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

AVBC

Avidia Bancorp posts investor presentation for June 2 conference

Avidia Bancorp, Inc. May 28, 2026, 4:32 PM ET other Items 7.01, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

ONDS

Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares

Ondas Inc. May 28, 2026, 4:09 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

CubeSmart, L.P.

CubeSmart files 8-K with investor slide presentation; no material new information disclosed

CubeSmart, L.P. June 1, 2026, 4:22 PM ET other Items 2.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: other

Filing page SEC filing

OLP

OLP furnishes June 2026 investor presentation; full content not available in filing excerpt

ONE LIBERTY PROPERTIES INC June 1, 2026, 12:49 PM ET other Items 2.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: other

Filing page SEC filing

PAL

Proficient Auto Logistics to attend William Blair conference; sets Q2 2026 earnings call for Aug 10

Proficient Auto Logistics, Inc June 1, 2026, 5:29 PM ET other Items 7.01, 9.01

same SEC item: 9.01 same event type: other

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-25-004989

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.